Literature DB >> 33302530

Polysaccharide from Codium fragile Induces Anti-Cancer Immunity by Activating Natural Killer Cells.

Hae-Bin Park1,2,3, Juyoung Hwang1,2,3, Wei Zhang1, Seulgi Go2,3, Jihoe Kim2,3, Inho Choi2,3, SangGuan You4, Jun-O Jin1,2,3.   

Abstract

Natural polysaccharides exhibit beneficial immune modulatory effects, including immune stimulatory and anti-<span class="Disease">cancer activities. In this study, we examined the effect of Codium fragile polysaccharide (CFP) on natural killer (NK) cell activation, and its effect on tumor-bearing mice. Intravenous CFP treatment of C57BL/6 mice resulted in the upregulation of CD69, which is a marker associated with NK cell activation. In addition, intracellular levels of interferon (IFN)-γ and the cytotoxic mediators perforin and granzyme B were markedly increased in response to the CFP treatment of splenic NK cells. IFN-γ production by NK cells was directly induced by CFP, whereas the upregulation of CD69 and cytotoxic mediators required IL-12. Finally, intraperitoneal treatment with CFP prevented CT-26 (murine carcinoma) tumor cell infiltration in the lungs, without significantly reducing the body weight. In addition, treatment with CFP prevented B16 melanoma cell infiltration in the lung of C57BL/6 mice. Moreover, the anti-tumor effect was diminished by the depletion of NK cells. Therefore, these data suggest that CFP may be used as an NK cell stimulator to produce a phenomenon that contributes to anti-cancer immunity.

Entities:  

Keywords:  Codium fragile polysaccharide; anti-cancer effect; cytotoxicity; granzyme B; natural killer cell; perforin

Mesh:

Substances:

Year:  2020        PMID: 33302530      PMCID: PMC7763488          DOI: 10.3390/md18120626

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  42 in total

1.  The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function.

Authors:  C Wagner; G M Hänsch; S Stegmaier; B Denefleh; F Hug; M Schoels
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

2.  Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells.

Authors:  Sami Mahrus; Charles S Craik
Journal:  Chem Biol       Date:  2005-05

3.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

Authors:  Stephanie Dillon; Sudhanshu Agrawal; Kaustuv Banerjee; John Letterio; Timothy L Denning; Kyra Oswald-Richter; Deborah J Kasprowicz; Kathryn Kellar; Jeff Pare; Thomas van Dyke; Steven Ziegler; Derya Unutmaz; Bali Pulendran
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

Review 5.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

6.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

Authors:  Hosoon Choi; Ryang Hwa Lee; Nikolay Bazhanov; Joo Youn Oh; Darwin J Prockop
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

7.  NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

Authors:  Christophe Borg; Abdelali Jalil; Diego Laderach; Kouji Maruyama; Hiro Wakasugi; Sabine Charrier; Bernhard Ryffel; Alessandra Cambi; Carl Figdor; William Vainchenker; Anne Galy; Anne Caignard; Laurence Zitvogel
Journal:  Blood       Date:  2004-07-08       Impact factor: 22.113

Review 8.  Fucoidan: structure and bioactivity.

Authors:  Bo Li; Fei Lu; Xinjun Wei; Ruixiang Zhao
Journal:  Molecules       Date:  2008-08-12       Impact factor: 4.411

Review 9.  Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.

Authors:  Xiaosong Li; Min Min; Nan Du; Ying Gu; Tomas Hode; Mark Naylor; Dianjun Chen; Robert E Nordquist; Wei R Chen
Journal:  Clin Dev Immunol       Date:  2013-03-04

10.  Cancer immunotherapy using a polysaccharide from Codium fragile in a murine model.

Authors:  Hae-Bin Park; Seong-Min Lim; Juyoung Hwang; Wei Zhang; SangGuan You; Jun-O Jin
Journal:  Oncoimmunology       Date:  2020-06-01       Impact factor: 8.110

View more
  4 in total

Review 1.  Molecular targets of exercise mimetics and their natural activators.

Authors:  Young Jin Jang; Sanguine Byun
Journal:  BMB Rep       Date:  2021-12       Impact factor: 4.778

2.  Sulfated Polysaccharide Extracted from the Green Algae Codium bernabei: Physicochemical Characterization and Antioxidant, Anticoagulant and Antitumor Activity.

Authors:  Fabian A Figueroa; Roberto T Abdala-Díaz; Claudia Pérez; Virginia Casas-Arrojo; Aleksandra Nesic; Cecilia Tapia; Carla Durán; Oscar Valdes; Carolina Parra; Gastón Bravo-Arrepol; Luis Soto; José Becerra; Gustavo Cabrera-Barjas
Journal:  Mar Drugs       Date:  2022-07-15       Impact factor: 6.085

3.  Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish.

Authors:  Lei Wang; Jun-Geon Je; Caoxing Huang; Jae-Young Oh; Xiaoting Fu; Kaiqiang Wang; Ginnae Ahn; Jiachao Xu; Xin Gao; You-Jin Jeon
Journal:  Mar Drugs       Date:  2022-06-13       Impact factor: 6.085

Review 4.  A concise review of the bioactivity and pharmacological properties of the genus Codium (Bryopsidales, Chlorophyta).

Authors:  Maria Dyah Nur Meinita; Dicky Harwanto; Jae-Suk Choi
Journal:  J Appl Phycol       Date:  2022-10-13       Impact factor: 3.404

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.